ALL MULTIPLEX PANEL (t(9;22),t(12;21),t(1;19),t(4;11)
- Report in 1 hr
- Serum
₹6,000
Price
₹7,000
or call 77900 98009
AML PROGNOSTIC PANEL (AML-ETO/INV.-16/PML-RARA/FLT-3)
₹7,000
The AML prognostic panel uses molecular testing (PCR) to detect four key genetic changes in acute myeloid leukemia (AML):
Results help classify AML, predict outcomes, and monitor minimal residual disease.
An AML prognostic panel is advised by a hematologist at the time of AML diagnosis, ideally before starting treatment, to assess risk and identify targeted therapy options. It is urgent when APL is suspected, especially with bleeding or clotting problems. It may be repeated during and after treatment to monitor residual disease and detect relapse.
No fasting is required for an AML prognostic panel done on a blood sample. If a bone marrow sample is needed, inform your doctor about blood thinners or bleeding disorders, and fast only if sedation is planned. Ideally, give the sample before starting chemotherapy. Samples must reach the lab promptly, as RNA degrades quickly.
No, fasting is not required for an AML prognostic panel when a blood sample is used. You can eat and drink normally. However, if the test is done on a bone marrow sample under sedation, you may need to fast for 4–6 hours. Follow your doctor’s specific instructions.
₹6,000
₹10,000
₹8,000
₹15,000
Tell us what your doctor has prescribed and our team will confirm the right test and book it for you.